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DNA  interstrand  cross-links  (ICLs)  represent  a physical  barrier  to the  progression  of cellular  machinery
involved  in  DNA metabolism.  Thus,  this  type  of adduct  represents  a serious  threat  to  genomic  stability  and
as  such,  several  DNA  repair  pathways  have  evolved  in both  higher  and  lower  eukaryotes  to  identify  this
type  of  damage  and restore  the  integrity  of  the  genetic  material.  Human  cells  possess  a  specialized  ICL-
repair  system,  the  Fanconi  anemia  (FA)  pathway.  Conversely  yeasts  rely  on  the concerted  action  of  several
DNA  repair  systems.  Recent  work  in  higher  eukaryotes  identiﬁed  and characterized  a  novel  conservedCL
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FA  component,  FAN1  (Fanconi  anemia-associated  nuclease  1, or FANCD2/FANCI-associated  nuclease  1).
In  this  study,  we  characterize  Fan1  in  the  yeast  Schizosaccharomyces  pombe.  Using  standard  genetics,  we
demonstrate  that Fan1  is  a key  component  of  a  previously  unidentiﬁed  ICL-resolution  pathway.  Using
high-throughput  synthetic  genetic  arrays,  we  also  demonstrate  the  existence  of  a third  pathway  of  ICL
repair,  dependent  on the  SUMO  E3 ligase  Pli1.  Finally,  using  sequence-threaded  homology  models,  we
predict  and  validate  key residues  essential  for Fan1  activity  in  ICL repair.. Introduction
Interstrand cross-links (ICLs) represent a particularly insidious
hreat to genomic stability. These adducts create covalent bonds
inking the two DNA strands in a duplex, generating an abnor-
al structure that poses a physical obstacle to the progression
f cellular machinery like DNA replisomes [1,2]. The mechanisms
nderlying the response to ICLs in unicellular organisms depend
n components involved in many of the major DNA repair path-
ays: nucleotide excision repair (NER), base excision repair (BER),
ismatch repair (MMR), post-replication repair (PRR, comprising
ranslesion synthesis, TLS) and homologous recombination (HR)
2]. Conversely, only a few proteins have been identiﬁed as spe-
iﬁc to the response to ICLs. In Saccharomyces cerevisiae, Pso2/Snm1
as been identiﬁed as a key player in the response to interstrand
ross-linking agents [3–5]. A role for Snm1/Pso2 has been postu-
ated where its exonuclease activity resects the DNA ﬂanking the
CL to facilitate TLS or homologous recombination [6,7]. Although
ittle is known about the resolution of DNA ICLs in the ﬁssion yeast
chizosaccharomyces pombe, the corresponding Pso2 nuclease has
∗ Corresponding author. Tel.: +44-1273-678122; fax: +44-1273-678121.
E-mail  address: a.m.carr@sussex.ac.uk (A.M. Carr).
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been similarly shown to be required for normal resistance to ICL-
inducing agents [8].
In  higher eukaryotes, multiple DNA repair pathways are also
involved in the resolution of ICLs, albeit the existence of the special-
ized Fanconi anemia (FA) pathway [9] marks a signiﬁcant difference
compared to the yeasts. The current model for the involvement
of the FA pathway in ICL repair is as follows: the ICL is recog-
nized by FANCM-FAAP24 bound to the recently discovered MHF
complex [9–11]. FANCM-FAAP24-MHF recruits a downstream E3
ubiquitin ligase complex known as the “FA core complex”, which
in turn monoubiquitinates FANCD2 and FANCI on chromatin [9,12].
FANCD2-FANCI then recruits further downstream factors and inter-
acts with HR and TLS proteins, ﬁnally facilitating HR-dependent ICL
repair [9]. It is also proposed that a parallel crosstalk with S-phase
checkpoint proteins mediates and coordinates ICL repair with other
DNA damage response mechanisms [9].
Recent work in higher eukaryotes identiﬁed and characterized
FAN1 (Fanconi anemia-associated nuclease 1, or FANCD2/FANCI-
associated nuclease 1) [13–18]. Human FAN1 colocalizes to
ICL-induced foci with and dependently on monoubiquitinated
FANCD2, suggesting a role with the FA pathway. Defects in homol-
Open access under CC BY license.ogous recombination in FAN1-depleted cells suggest that this
protein is involved in the HR processes linked to ICL repair. As
DSB resection is not impaired in the absence of FAN1 and RAD51
foci persist in FAN1-depleted cells, it has been proposed that FAN1
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ay  be required for late stages of HR-dependent repair [14,15]. A
omolog of FAN1 is present in the ﬁssion yeast S. pombe, but not in
he budding yeast S. cerevisiae. Thus, the appearance of FAN1 earlier
han the FA core complex-dependent pathway on the evolutionary
cale suggests that the role of this component is either functionally
istinct from the canonical FA pathway of higher eukaryotes or is
egulated by this pathway. For this reason, the study of Fan1 in S.
ombe has the potential for revealing mechanisms of ICL repair in
igher eukaryotes which act in parallel with, or are controlled by,
he FA pathway.
In  the present study, we  investigate the function of S. pombe Fan1
the gene is named fan1 following the work discussed above) using
tandard and high-throughput genetics. We  demonstrate that Fan1
s a novel component of a Pso2-independent ICL resolution pathway
nd genetically dissect these two pathways to assign epistatic rela-
ionships with known components of DNA damage repair pathways
nvolved in ICL repair. Using high-throughput synthetic genetic
rrays to explore genetic relationships in the response to ICL-
nducing agents, we identify the existence of an additional ICL
esolution pathway dependent on the SUMO E3 ligase Pli1. Finally,
e identify key Fan1 residues necessary for its activity.
.  Material and methods
.1.  DNA damaging agents
UV  irradiation was performed with a Stratagene® Stratalinker®
sing the settings (J/m2) indicated. Other drugs used, all from
IGMA®: methyl methanesulfonate (MMS), cat. no. 129925; cis-
latin (cis-platinum(II)diammine dichloride, product no. P4394;
itomycin C (MMC), cat. no. M0503; HN1 (2-chloro-N,N-
imethylethylamine hydrochloride), product no. 24362; HN2
mechlorethamine hydrochloride), product no. 122564; cyclohex-
mide, product no. C7698 (100 mg/l from a 100 mg/ml  stock in
MSO).
.2. Strains
A  list of all the strains used in this study is provided in sup-
lementary Table 4. Details of the strain construction for speciﬁc
utants are given below.
.3.  fan1-d strain construction
Two  independently-derived fan1-d mutants (both fan1::kanMX;
anMX confers resistance to the drug geneticin, or G418) have
een analysed in parallel in this study. The ﬁrst mutant (3909)
as kindly donated by Professor Paul Nurse; the second mutant
14152) is derived from the Bioneer® S. pombe deletion mutant
ibrary (http://pombe.bioneer.co.kr/). The two strains were ver-
ﬁed  by Southern blot. To allow a ﬂexible and rapid series of
enetic crosses between different deletion mutants, the original
anMX deletion cassettes in the 3909 and 14152 strains were
eplaced with a natMX6 deletion cassette, which confers resis-
ance to nourseothricin [19]. The natMX6 null mutants derived
rom 3909 and 14152 were named 3909N and 14152N, respec-
ively. These new mutants showed the same sensitivity to the
rugs used in this study as the original 3909 and 14152 strains
data not shown). The two independently derived mutants always
howed consistent sensitivity to the drugs tested. The 3909/3909N
nd 14152/14152N strains were used both in parallel for nearly all
he experiments conducted, although in the interest of space only
ne of the two mutant is usually presented in the ﬁgures of this
tudy. fan1 mutants were created employing site-directed muta-
enesis using a Stratagene QuikChange® kit as described in [20] andir 12 (2013) 1011– 1023
Recombinase-Mediated Cassette Exchange (RMCE) as described in
[21].
2.4. Spontaneous mutation rate assays
Single colonies were isolated on YEA from individual streaks.
Eleven colonies from each strain were grown in 5 ml  YE in individ-
ual tubes. Samples were incubated at 30 ◦C for 48 h to stationary
phase. Cultures were serially diluted as follows: 10 l saturated cul-
ture in 1 ml H2O; 10 l of this dilution into 1 ml H2O.  A 50 l of this
dilution were plated on YE-Agar (YEA) plates. A 50 l of saturated
culture were plated on YE-5-FOA (5-Fluoroorotic acid; Melford®
F5001) plates (0.1% ﬁnal concentration). Plates were incubated for
3–4 days at 30 ◦C. Spontaneous mutation rates were calculated by
the Lea-Coulson method of the median (Rosche and Foster, 2000;
Foster, 2006).
2.5.  In vivo survival assays: Spot tests
Strains were inoculated in 5 ml  YE and grown at 30 ◦C o/n. 107
cells from each logarithmically growing culture were harvested and
resuspended in 1 ml  water. Four serial 1/10 dilutions were pre-
pared from each culture. A 10 ul were spotted onto YEA plates added
with increasing doses of DNA damaging agents. All the spots were
deposited in duplicates on the same plate to guarantee an inter-
nal control. Plates were incubated at 30 ◦C for 3 days. Images were
acquired with a Syngene® Ingenius® apparatus.
2.6. In vivo survival assays: Survival curves
A 2 × 108 cells grown to exponential phase were centrifuged and
washed with PBS. Pellets were resuspended in 10 ml  and split into
ﬁve 2 ml  aliquots in 15 ml  tubes. Each drug dilution was  inoculated
into the 2 ml  aliquoted cultures and tubes incubated at 30 ◦C with
shaking for 1 h. Approximately 200 cells were plated onto YEA and
grown at 30 ◦C for 3–4 days.
2.7.  Automated Screening of the Bioneer deletion library
Note: all the parameters of the programs indicated below are
detailed in the supplementary section. A loopful of query mutant
(Q) was  inoculated from a fresh patch into 15 ml YE + NAT and
grown for at least 6 h. The above culture was  poured into an empty
PlusPlate® (“Q bath”). Once thawed, library plates were replicated
onto YEA PlusPlates®: four liquid 96-well plates combined onto
one YEA PlusPlate® (384 spots) [PROGRAM 1, TWICE PER ARRAY].
A 384 agar plate was  build using the Q bath as a source (“Q YEA
PlusPlates®”) [PROGRAM 2, TWICE PER ARRAY]. Cells were grown
for 2–3 days at 30 ◦C (or until colonies are grown to satisfac-
tory size). Each library was  replicated to fresh YEA PlusPlates® (“L
YEA PlusPlates®”) [PROGRAM 3]. Mating: colonies were combined
from the L and Q YEA PlusPlates® onto ELN PlusPlates® [PRO-
GRAM 4, RUN TWICE PER ARRAY]. ELN PlusPlates® were incubated
at 25 ◦C for 4 days. YEA PlusPlates® were incubated at 30 ◦C for
3 days: pictures were taken approximately every 12 h to moni-
tor the ﬁtness of the single mutants. Spore germination: colonies
were replicated from ELN PlusPlates® to YEA PlusPlates® [PRO-
GRAM 5] and incubated at 30 ◦C for 3 days. Selection 1: colonies
were replicated from YEA PlusPlates® to YE + GC PlusPlates® [PRO-
GRAM 5] and incubated at 30 ◦C for 2–3 days (or until colonies
have grown to satisfactory size). Selection 2: cells were replicated
from YE + GC PlusPlates® to YE + GNC PlusPlates® [PROGRAM 3]
and incubate at 30 ◦C for 1–3 days. Pictures to assess the ﬁtness
of double mutants were taken at this stage every approximately
12 h.
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Table  1
Fan1  is not involved in the suppression of spontaneous mutation rate. Spontaneous forward mutation rate of fan1-d mutants in cdc6+ and cdc6-L591M backgrounds. Data from
three  independent experiments. For each strain, 11 colonies were grown to saturation at 30 ◦C for 48 h. Fluctuation analysis was performed as described in Section 2.
Mutation rate/cell division
Experiment 1 Experiment 2 Experiment 3 Average Standard error Fold elev.
cdc6+ 8.09E − 10 5.27E − 10 5.65E − 10 6.33E − 10 8.85E − 11 1
cdc6+  fan1-d (3909) 9.98E − 10 8.45E − 10 9.17E − 10 9.20E − 10 4.42E − 11 1
cdc6+  fan1-d (14152) 6.49E − 10 5.74E − 10 5.02E − 10 5.75E − 10 4.24E − 11 1
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cdc6-L591M  fan1-d (3909) 2.55E − 06 6.35E − 06 
cdc6-L591M  fan1-d (14152) 1.90E − 06 2.93E − 06 
For the assessment of resistance to DNA damaging agents,
ells were replicated from YE + GNC PlusPlates® to YE PlusPlates®
dded with different concentrations of chosen DNA damaging
gents [PROGRAM 3]. Plates were incubated at 30 ◦C for 2-4 days
nd pictures were taken approximately every 12 h. Pictures were
aken using a Syngene® Ingenius® apparatus. Software used for
olony size analysis: HT Colony Grid Analyser 1.1.0/1.1.7, Adobe®
hotoshop® CS5 Extended, Microsoft® Excel® 2007/2010.
. Results
.1. The Fanconi anemia—Associated nuclease Fan1 is not
nvolved in the suppression of DNA spontaneous mutation rate
Human  FAN1 (also known as KIAA1018) has been shown to
nteract with MMR  components such as MLH1, PMS1 and PMS2
13,14,22]. Thus, we set out to test whether a similar scenario holds
rue for SpFan1, and whether this protein could be involved in
he mismatch repair pathway. As we were unable to detect direct
hysical interactions of SpFan1 with other MMR  components (data
ot shown), we performed a forward mutation assay in order to
etermine the rate of spontaneous mutation in fan1-deleted cells.
n this system, the readout is the switch from uracil autotrophy
o uracil heterotrophy. The estimated mutation rate during DNA
eplication in eukaryotic cells is lower than 1 mutation every 109
ases [23], which would be undetectable by our current mutation
ssays. In S. cerevisiae, a mutation in the catalytic subunit of poly-
erase delta (Pol3-L615M) leads to a 7-fold increased spontaneous
utation rate with no measurable changes in other phenotypes
onitored [24]. In our study, the background spontaneous muta-
ion rate was therefore increased to detectable levels by using a
train harbouring the corresponding mutation in polymerase delta,
dc6 (cdc6-L591M) [25].
In  a cdc6-L591M background, the mutation rate is increased
o approximately 1 in 106 (Table 1; consistent with [25]). How-
ver, no signiﬁcant increase in this spontaneous mutation rate was
bserved following concomitant deletion of fan1. These data argued
gainst a direct involvement of SpFan1 in the MMR  pathway.
.2.  Fan1 is a component of a Pso2-independent interstrand
rosslink repair pathway
In  order to determine whether SpFan1 could be involved in
ther pathways of DNA repair, we performed in vivo survival
ssays to assign genetic interactions between SpFan1 and known
omponents of characterized repair pathways involved in the ICL
esponse. To assess the response of fan1-d mutants to a vari-
ty of DNA lesions, the two SpFan1 deletion mutants 3909 and
4152 were initially back-crossed twice to a wild-type strain
nd ﬁve independent G418-resistant colonies were isolated and
ested under increasing concentrations of various DNA damaging
gents. All the fan1 deletion isolates showed wild-type sensitivity
o UV, camptothecin (CPT), methyl methanesulfonate (MMS)  and2.82E − 06 5.25E − 06 2.81E − 06 1
3.37E − 06 4.09E − 06 1.16E − 06 1
2.99E − 06 2.61E − 06 3.54E − 07 0
hydroxyurea (HU) (data not shown). However, a subtle but repro-
ducible sensitivity was observed when fan1-d cells were exposed
to cis-platinum diammine-dichloride (cisplatin, CDDP) and mito-
mycin C (MMC). These drugs belong to a family of DNA damaging
agents that induce covalent DNA interstrand cross-links [2]. The
mild sensitivity towards ICL-inducing agents suggested that SpFan1
is implicated in ICL repair, but that its role overlaps with the func-
tion of other components of the DNA repair machinery.
To test this, the original 3909 and 14152 fan1 null mutants
were crossed with a series of deletion mutants of genes reported
to be involved in the ICL resolution pathway, either in S. pombe
or in the budding yeast S. cerevisiae. In S. pombe, the nuclease
Pso2 (also known as Snm1 in cerevisiae) has been shown to be
speciﬁcally required for normal resistance to ICL-inducing agents
[8]. When exposed to increasing doses of cisplatin and MMC,
the fan1-d pso2-d double mutant showed a dramatic reduction
in viability compared to the corresponding single mutants or
the wild-type (wt) control strain (Fig. 1A, left panel). In order
to conﬁrm that SpFan1 is speciﬁcally involved in ICL repair, cell
survival assays were repeated for fan1-d and pso2-d using bis(2-
chloroethyl)methylamine (HN2, mechloretamine), an agent shown
to generate a higher proportion of DNA interstrand cross-links com-
pared to cisplatin [2]. When exposed to increasing concentrations
of HN2, fan1-deleted cells showed a marked decrease in viabil-
ity only when combined with pso2 deletion (Fig. 1A, right panel).
As a further control, the same experiment was conducted in the
presence of HN1 (2-dimethylaminoethylchloride hydrochloride), a
mono-functional nitrogen mustard which does not form ICLs [26].
None of the strains treated with this agent, including the double
mutant pso2-d fan1-d, showed any sensitivity to this agent (data
not shown).
Taken together, these data conﬁrm that SpFan1 is a novel com-
ponent of the DNA repair pathway that speciﬁcally acts to repair
cross-links linking covalently the two  strands of a DNA molecule,
and that SpFan1 and SpPso2 act in parallel pathways or subpath-
ways.
3.3. The NER nuclease Rad13 is involved only in the
pso2-dependent ICL repair pathway
ICL repair mechanisms in lower and higher eukaryotes have
proven to be elusive due to the intersection of different DNA repair
pathways. In S. cerevisiae, components of the nucleotide excision
repair (NER), post-replication repair (PRR) and homologous recom-
bination (HR) pathways have all been implicated in the resolution
of interstrand cross-links [2]. To test whether Fan1-dependent ICL
repair intersects with these pathways, a series of double and triple
mutants were created and tested for sensitivity to cisplatin.
rhp18,  the ﬁssion yeast gene encoding the homolog of S.
cerevisiae Rad18 involved in post-replication repair[2], displayed
hypersensitivity to cisplatin to concentrations as low as 50 M
(supplementary Fig. 1). The combination of the fan1 and rhp18
mutations did not display increased sensitivity to cisplatin,
1  Repa
w
o
t
o
d
t
F
c
t
c
d
d
c014 Y. Fontebasso et al. / DNA
hereas a mild but reproducible increase in sensitivity was
bserved when pso2-d was  combined with rhp18-d (supplemen-
ary Fig. 1). This indicates that Rhp18 is involved in the resolution
f ICL adducts in a step that is common to the Fan1 pathway. The
eletion of the nuclease Exo1 displayed no signiﬁcant sensitivity
o ICL-inducing agents, and only a marginal increased sensitivity in
ig. 1. Fan1 is a novel component of a pso2-independent interstrand crosslink repair pathwa
isplatin  and MMC.  Top panel: logarithmically grown cultures were spotted in four 1:10 se
he agents in the amount indicated. Bottom panel: due to the short half-life of HN2, sensitiv
ultures to the indicated dose. Error bars represent the standard error of the mean of thre
eletion mutants to cisplatin (fan1-d: 14152N background). (C) Sensitivity of combinatio
eletion  mutants. rad3-d is used as a standard hypersensitive control for the efﬁcacy of t
isplatin; MMC, mitomycin C; HN2, bis(2-chloroethyl) methylamine; UV, ultra-violet irrair 12 (2013) 1011– 1023
combination with pso2-d, fan1-d (double mutants) or with pso2-d
fan1-d (triple mutant) (data not shown).Of all the mutants tested (including msh2-d, chk1-d and cds1-d),
rad13 deletion showed the most dramatic reduction in viability,
compared to the wt  strain, when exposed to cisplatin (1b, top
panel). SpRad13 (HsXPG, ScRad2) is a nuclease centrally involved
y in S. pombe. (A) Sensitivity of combinations of fan1 and pso2 deletion mutants to
rial dilutions starting from 107 cells (ﬁrst spot on the left) on YEA plates containing
ity to this drug was assessed by exposing 4 × 107 cells from logarithmically growing
e independent experiments. (B) Sensitivity of combinations of fan1, pso2 and rad13
ns of fan1, pso2 and rad51 deletion mutants. (D) Sensitivity of combinations of fml1
he agents used. UV treatment was included as a control for rad51 sensitivity. cispl,
diation.
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mFig. 1. 
n the NER pathway that is required for the initial incision at
arly steps of ICL repair in S. cerevisiae [2]. Interestingly, rad13XPG
ull mutant sensitivity was signiﬁcantly further increased when
ombined with a deletion of the gene coding for Fan1, but not
hen combined with deletion of the gene coding for Pso2 (Fig. 1B,
ompare top and bottom panel). Interestingly, the triple mutant
an1-d pso2-d rad13-d (14152N background) phenocopied the fan1-
 pso2-d strain (Fig. 1B, top and bottom panels). The same pattern
f sensitivity was observed for the 3909N background (data not
hown). These data suggest that, in S. pombe, Rad13XPG is involved
n the resolution of DNA interstrand cross-links in a Pso2- but not in
he Fan1-dependent pathway. We  decided to test whether a similar
ifferential involvement is true also for SpRad16, the homolog of
he DNA repair endonuclease XPF in human. The deletion of rad16
aused a dramatic sensitivity to cisplatin (supplementary Fig. 2).
owever, no further increased sensitivity was noticed in the double
utants pso2-d rad16-d or fan1-d rad16-d, nor in the triple mutantinued)
pso2-d  fan1-d rad16-d (supplementary Fig. 2). This result suggests
that rad16 is epistatic to both the Fan1- and the Pso2-dependent
pathways.
3.4. Homologous recombination is required for ICL resolution
downstream the Fan1- and Pso2-dependent pathways
Homologous recombination has been shown to be involved
in the repair of ICLs in the budding and the ﬁssion yeast [2,8].
Rad51 protein is required for most recombination events in yeast
[27]. The deletion of both fan1 and rad51 led to a marked drop
in viability compared to wild-type and single mutants when cells
were exposed to cisplatin, but not when they were exposed to
UV (Fig. 1C), which consistent with a predominant involvement
for Rad51 but not Fan1 in the response to UV-induced damage.
In contrast, the deletion of both pso2 and rad51 did not increase
the sensitivity to cisplatin compared to rad51 single mutant cells
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Fig. 1C, bottom panel). Interestingly, the triple deletion of the genes
oding for Fan1, Rad51 and Pso2 resulted in the most dramatic
ecrease in viability compared to all the combinations of mutants
ested (Fig. 1C, bottom panel). These data suggest a crucial role for
ad51 in the resolution of ICLs outside the Pso2 and Fan1 pathways.
he notable difference in sensitivity between the combinations of
an1-d rad51-d and pso2-d rad51-d double mutants further sug-
ests differential extents for the involvement of Rad51-dependent
rocesses in the Pso2 and Fan1 pathways of ICL resolution.
.5.  The conserved Fanconi anemia component Fml1 acts in a
so2-independent ICL resolution pathway
Fml1 is the S. pombe homolog of the human FANCM heli-
ase/translocase, a component of the Fanconi anemia pathway
28,29]. Fml1 has been previously shown to be required for wild-
ype resistance to interstrand cross-linking agents such as cisplatin
30]. Recent work on the homolog Mph1 in S. cerevisiae indicates
hat Mph1 and Pso2 act in independent pathways of ICL resolu-
ion upon exposure to HN2 [31]. To test whether the same scenario
olds true in S. pombe, we created combined double mutants of
ml1-d and pso2-d or fan1-d and assessed the sensitivity of these
utants to cisplatin. Whereas the combination of fml1-d and fan1-
 did not increase the sensitivity to the drug compared to the single
utants, the concomitant deletion of fml1 and pso2 showed a more
ccentuated sensitivity (Fig. 3D). This data suggests that, in paral-
el with the situation in the budding yeast, the conserved Fanconi
nemia component Fml1 and the nuclease Pso2 act on independent
athways in response to resolution of DNA interstrand adducts.
.6.  The nuclease and the SAP DNA binding domain are required
or  Fan1 activity
Previous work has indicated the presence of two conserved
omains, shared between human and S. pombe Fan1 (Fig. 2A): a
AP-type DNA binding motif (SAF-A/B, Acinus and PIAS) thought
o be involved in chromosomal reorganization [32] and a VRR nuc
Virus-type Replication-Repair Nuclease) domain [13], which is
ssociated with DNAses involved in DNA repair and is charac-
erized by a relatively conserved PD-(D/E)XK motif [33,34]. We
ecided to test whether these domains were required for nor-
al functionality of SpFan1. From amino-acid sequence alignments
13] three residues within the S. pombe VRR nuc catalytic motif –
sp651, Glu666, Lys668 – were selected for mutagenesis (Fig. 2A);
651A, D651N, E686Q, K668A. For the SAP domain, as only a
ingle residue was strongly conserved between the human and
he S. pombe homologs (Leu159) [13], we decided to generate
equence-threaded homology models, using the Phyre2 webserver
http://www.sbg.bio.ic.ac.uk/phyre2) to identify alternative amino
cids to target for mutagenesis. Using two models, based on sep-
rate templates (PDB: 2rnn; 2kvu), we were able to identify a
ositively-charged face, comprised of amino acids Arg160, Arg164,
ys171, and Arg173 (Fig. 2B). We  therefore designed speculative
harge-reversal mutants in this region to disrupt any potential
rotein-DNA interactions; R160E, R164E, K171E, R173E. Using
ite-directed mutagenesis we generated single and multi-point
utants in both the VRR nuc and SAP domain of spFAN1, then used
ecombinase-mediated cassette exchange [20] to introduce them
nto a pso2-deleted base strain, and tested them for sensitivity to UV
nd cisplatin. In addition, L159P and I176W mutants were designed
o speciﬁcally perturb/disrupt the overall fold of the SAP domain, as
ell as a deletion mutant removing the entire SAP domain (N-termrunc; removing the ﬁrst 193 amino acids of spFAN1).
As expected, the pso2-d fan1::NAT (null) double mutant base
train displayed a marked hypersensitivity when exposed to
oses of cisplatin as low as 50 M (Fig. 2C). All three nucleaseir 12 (2013) 1011– 1023
domain mutants, Fan1-D651A, Fan1-E666Q and Fan1-K668A, phe-
nocopied the pso2 fan1 double null mutant when exposed to
either UV or cisplatin (Fig. 2C). The substitution of D651 with the
structurally similar, but formally non-charged, residue asparagine
(Fan1-D651N) showed the same hypersensitivity as fan1-D651A
(Fig. 2C). Similarly, the SAP domain mutants L159P, the quadruple
charge-reversal mutant fan1-R160E/R164E/K171E/R173E and the N-
terminal truncation mutant all phenocopied the pso2 fan1 double
null mutant (Fig. 2D). Taken together, these data suggest that both
the VRR nuc nuclease domain and the SAP DNA binding domain
are essential for SpFan1 activity in vivo. Interestingly, the potential
fold-disrupted mutant (fan1-I176W) appeared to be less sensitive
than the other SAP domain mutants (Fig. 2D), suggesting that dis-
rupting the corresponding alpha-helix affects Fan1 protein activity
to a lesser extent.
3.7. High-throughput screens of synthetic genetic arrays identify
a  role for Pli1 in ICL resolution
In  order to detect genetic interactions between fan1 and other
components of DNA metabolism, we set up a high-throughput
genetic screen by constructing synthetic genetic arrays (SGAs)
using the PEM-2 (pombe epistatic mapper 2) as described in [35].
Firstly, the screen involved the generation of arrays of haploid
double mutants created by crossing a fan1-deleted query strain
with 2034 individual null mutants from the Bioneer® V2 deletion
library (Fig. 3A and supplementary Fig. 3). The resulting double
mutants were initially grown on standard media and the ﬁtness
of each double mutant colony assessed by computational analy-
sis of colony size and classiﬁed according color-coded categories
of deviation from the median colony size following the criteria
(see supplementary Fig. 5). The full list of disruptants showing syn-
thetic lethal/sickness and alleviating interactions with the fan1-d
background is provided in supplementary Tables 1–3.
The  double mutants were subsequently transferred to plates
supplemented with increasing concentrations of cisplatin. The
hypersensitivity to cisplatin exposure was  again assessed by com-
putational analysis of colony size. Brieﬂy, synthetic genetic arrays of
double null mutants were assessed for consistent, signiﬁcant and
progressive reduction of colony size upon increasing concentra-
tions of cisplatin when compared to the median colony size of the
population of double mutants growing on the same plate. A full
description of the method applied is detailed in the supplementary
section.
By intersecting the data from three independent screens, six
candidates showed a progressive and consistent reduction in
colony size upon increasing concentrations of cisplatin (Table 2).
The presence of the DNA repair nuclease Rad13 in the list validated
of the methodology, as the deletion of this gene already showed
synergistic hypersensitivity to cisplatin when combined with fan1
deletion (Fig. 1B).
Because  this initial analysis was  performed on the double
mutants, it does not preclude that the hypersensitivity to cisplatin
is due solely to the single mutation from the deletion library,
and not to its combination with fan1-d. Thus, to assess whether
the hypersensitivity shown in the screen represented synergis-
tic hypersensitivity, and to provide a further validation of the
methodology, double disruptants were recreated from indepen-
dently derived mutants and tested by employing standard in vivo
survival assays.
SpRad1  and SpHus1 are part of the 9-1-1 clamp complex, which
play crucial roles in checkpoint activation following DNA damage
[36,37]. SpRad17 acts as a clamp loader for the trimeric complex
[37]. Consistently, all these three highly correlated factors were
pulled out in the screen. SpRad9, third component of the 9-1-1 com-
plex, was absent in the library of deletion mutants tested. When
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Table  2
Double mutants (background: fan1-d mutant) that showed progressive increased sensitivity to cisplatin in all the three independent screens. Gene IDs, Bioneer® plate
reference, gene names and descriptions are extracted from the strain list provided with the Bioneer® deletion mutant haploid set.
Gene ID Bioneer® plate Ref. Gene name Description
SPAC1687.05 V2-05-A01 pli1 SUMO E3 ligase Pli1
SPAC1952.07  V2-05-B05 rad1 Checkpoint clamp complex protein Rad1
SPBC3E7.08c V2-13-C04 rad13 DNA repair nuclease Rad13
SPAC20G4.04c V2-19-C02 hus1 Checkpoint clamp complex protein Hus1
SPAC9E9.14 V2-28-D07 vps24 Vacuolar sorting protein Vps24
SPAC14C4.13 V2-30-G05 rad17 RFC related checkpoint protein Rad17
Fig. 2. The nuclease and the SAP domains of Fan1 are required for wild-type resistance to cisplatin. (A) Amino acid sequence alignment between HsFAN1 and SpFan1. Manually
annotated ClustalW2 alignment (http://www.ebi.ac.uk/Tools/clustalw2/index.html). The boxed regions indicate the conserved PD-(D/E)-XK nuclease motif [33]. Asterisks
indicate the residues mutated in our study (Leu159, Asp651, Glu666, Lys668 in the S. pombe homolog). These, plus additional mutants are listed in Fig. 3B (inset table). (B)
Phyre2  sequence-threaded models of the spFAN1 SAP domain. Molecular ‘cartoon’ representations of the structural models based on PDB templates 2rnn and 2kvu. Key
amino  acids are additionally show in stick representation. The extent, quality and detail of each model is indicated by the inset amino acid sequence alignment and associated
Phyre2 summary table. (C) Sensitivity of point mutations in the conserved residues of the nuclease domain to cisplatin and UV. A pso2-d background was  used in order to
compare  the effect of the mutations to the hypersensitive double mutant fan1-d pso2-d. Logarithmically grown cultures were spotted in four 1:10 serial dilutions starting
from 107 cells (ﬁrst spot on the left) on YEA plates containing the agents in the amount indicated. rad3-d is used as a standard hypersensitive control for the efﬁcacy of the
agents used. UV, ultra-violet irradiation; cispl, cisplatin; q. mutant, fan1-R160E R164E K171E R173E; N-term trunc, N-terminal truncation mutant d. Sensitivity of point and
truncation mutants in the SAP domain to cisplatin. As described under (C).
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ested for sensitivity to cisplatin, both the fan1-d mutants 3909N
nd 14152N showed a strong hypersensitivity when combined with
ad1-d, hus1-d or rad17-d (Fig. 3B). However, the single mutants
ere similarly highly sensitive, indicating an epistatic interaction
etween these checkpoint components and fan1. To determine
hether the same occurs for the third component of the 9-1-1
omplex SpRad9, independently derived double mutants fan1-d
ad9-d were constructed and tested by in vivo survival assays. Con-
istently with a common role as part of the 9-1-1 heterotrimer,
ad9-d phenocopied hus1-d and rad1-d, either as a single mutant
r in combination with fan1-d (Fig. 3B).
Intriguingly, fan1-d pli1-d was also pulled out as a hypersensi-
ive double deletion mutant. Pli1 is a SUMO (small ubiquitin-related
able 3
ouble mutants (background: pso2-d mutant) that showed progressive increased sensit
ene names and descriptions are extracted from the strain list provided with the Bioneer
Gene ID Bioneer® plate Ref. 
SPAC24B11.12c V2-05-D11 
SPBC3E7.08c  V2-13-C04 
SPAC11E3.04c V2-16-E10 
SPAC20G4.04c V2-19-C02 
SPCC23B6.05c V2-27-B11 
SPAC4D7.06c V2-27-E12 
SPAC14C4.13  V2-30-G05 inued)
modiﬁer) E3 ligase that has been associated with DNA  repair,
although its roles have not yet been fully elucidated [38]. When
tested using in vivo survival assays, independently constructed
fan1-d pli1-d mutants (3909 or 14152 background) showed hyper-
sensitivity to cisplatin compared to the wild-type, fan1-d and pli1-d
strains (Fig. 3C). This increased sensitivity is dramatic following
exposure to cisplatin and absent upon UV irradiation, indicating
that the two  proteins are required in response to the formation of
a signiﬁcant amount of DNA interstrand cross-links.Taken together, these ﬁndings conﬁrm that the application of
the computational analysis of colony size to the high-throughput
screen for sensitivity to cisplatin is an effective methodology,
as it facilitated the identiﬁcation of the involvement of the
ivity to cisplatin in two independent screens. Gene IDs, Bioneer® plate reference,
® deletion mutant haploid set.
Gene name Description
P-type ATPase
rad13 DNA repair nuclease Rad13
ubc13 Ubiquitin conjugating enzyme Ubc13
hus1 Checkpoint clamp complex protein Hus1
ssb3 DNA replication factor A subunit Ssb3
Siroheme synthase
rad17 RFC related checkpoint protein Rad17
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UMO E3 ligase Pli1 in the resolution of DNA interstrand cross-
inks.
.8. Further exploration of genetic relationships in the
so2-independent ICL repair pathway
As our high-throughput computational approach proved to be
ffective in identifying new factors acting in a parallel pathway with
an1 in response to ICL exposure, we adopted the same approach to
dentify potential genetic interactions triggered by cisplatin expo-
ure in the absence of the pso2-dependent ICL responses. Similarly
o the methodology described above, we assessed the reduction of
olony size in haploid double mutants generated by crossing a pso2-
eleted query mutant with a series of deletion mutants included in
he Bioneer® V2 deletion library. A selection of candidates, pre-
ented in Table 3, showed progressive dramatic sensitivity in two
ndependent screens as a consequence of exposure to increasing
oncentrations of cisplatin.
Interestingly, the 9-1-1 protein Hus1 and the clamp loader
ad17 were again identiﬁed as hypersensitive mutants, conﬁrming
he importance of these components in response to ICL. Similarly
o the screen with the fan1-deleted query mutant, we also pulled
ut Rad1 in one replica of the screen, but as the sensitivity was not
vident in the second replica, this candidate was not included in
he ﬁnal list. The reason for the lack of signiﬁcant sensitivity to cis-
latin in the second replica is unknown. However, as our previous
xperiments showed clearly that rad1 null mutant is hypersensi-
ive to cisplatin, we classify this as experimental noise, likely due
o cross-contamination with other strains, or due to the rise and
ver-growth of a cisplatin-resistant strain within the colony. All
he mutants pulled out as hits in the pso2-deleted cisplatin screen
ere subsequently re-made using the single mutants present in the
eletion library. A further independent test for cisplatin sensitivity
alidated the results obtained from the screen (supplementary Fig.
). Interestingly, all the null mutants identiﬁed in this branch of the
creen were not epistatic with Pso2 (supplementary Fig. 4).
.  Discussion
The data presented in this study substantiate a conserved role
or FAN1 in the resolution of interstrand cross-links across eukary-
tes. The prospective role for SpFan1 in the resolution of this type
f adducts was conﬁrmed not only by the sensitivity of the null
utant to a series of ICL-inducing agents, but also by the dramatic
ncrease in sensitivity to the same agents when the deletion of fan1
nd pso2 were combined (Fig. 1A).
.1. Genetic dependencies in the novel SpFan1-dependent
athway of ICL resolution
As  the nuclease SpPso2 was previously identiﬁed as a key com-
onent of the ICL response in S. pombe [8], our results suggested that
pFan1 is a key component of a novel pathway or sub-pathway of
CL repair, acting in parallel with the one dependent on SpPso2. The
nitial systematic genetic analysis with other double and triple dele-
ion mutants of candidate genes identiﬁed only one other dramatic
ig. 3. The PEM-2 screen identiﬁes a novel Pli1-dependent pathway of ICL repair. (A). Schemati
creen. The PEM-2 (Pombe Epistatic Mapper—2) approach is based on recessive resistanc
uery mutant. Step 2 (green panel): screen of the Bioneer® deletion mutant library. Mating
nd cyhR (at the native locus), conferring to the ﬁnal double deletion mutant resistance
ection and [35] for further details. (B). Sensitivity to cisplatin of the combination of muta
our  1:10 serial dilutions starting from 107 cells (ﬁrst spot on the left) on YEA plates contai
ontrol for the efﬁcacy of the agents used. The double mutants tested in this and the a
utants. fan1-d: 3909 and 14152 backgrounds. UV, ultra-violet irradiation; cispl, cisplatin
s  described under (B). (For interpretation of the references to color in this ﬁgure legendir 12 (2013) 1011– 1023
increased  combined sensitivity to interstrand cross-linkers: the
fan1-d rad13-d double mutant (Fig. 1B). SpRad13 (homolog of
Rad2Sc and XPGHs) is a core nuclease involved in the double inci-
sion step of the nucleotide excision repair pathway, 3′ to the lesion
[39]. The ﬁnding that the combination of pso2-d and rad13-d did
not lead to increased sensitivity to cross-linkers (Fig. 1B) places
this nuclease uniquely in the Pso2-dependent pathway of ICL res-
olution.
Consistently with other studies in eukaryotes, the E3 ubiqui-
tin ligase Rhp18 was  found to be required for wild-type resistance
to interstrand cross-links (supplementary Fig. 1 and [8,40–42].
However, only the combined deletion rhp18-d pso2-d showed
increased sensitivity to cisplatin compared to the most sensitive
single mutant (supplementary Fig. 1), suggesting that Rhp18 is
required for the Fan1- and not for the Pso2-dependent pathway.
In this context, the involvement of SpRhp18 in ICL repair might
echo what has been proposed in S. cerevisiae, where Rad18 would
be implicated in controlling DNA synthesis at late stages of ICL
processing in conjunction with Rad6. However, further work is
needed to support this hypothesis.
A fourth gene deletion found to confer sensitivity to cisplatin
was rad51-d, coding for the homolog of the recombination protein
Rad51 [43,44]. Interestingly, but not unexpectedly, the deletion of
rad51 showed increased sensitivity following exposure to cisplatin
when combined with either fan1 or pso2 deletion, compared to the
single mutants (Fig. 1C). Rad51 has been already implicated in ICL
repair in the ﬁssion yeast [45]. The data presented in this study
suggests that Rad51 would be involved in both the Fan1- and Pso2-
dependent pathways (Fig. 1C). In particular, the hypersensitivity of
rad51-d seems to be more dramatic in combination with fan1-d,
suggesting that the Fan1 pathway would rely on Rad51-dependent
homologous recombination to a lesser extent when compared to
the Pso2 pathway. It is also interesting to note that the triple dele-
tion strain fan1-d pso2-d rad51-d appears to be even more sensitive
compared to any of the cognate strains (Fig. 1C). This observation
might suggest that Rad51 has additional functions in ICL response
that are independent of Fan1 and Pso2. Alternatively, it may reﬂect
the fact that the agents used do not exclusively induce ICLs.
Finally,  the systematic genetic analysis led to the discovery of
the epistatic relationship between Fan1 and Fml1, the FANCM heli-
case/translocase homolog in S. pombe. To our knowledge, prior to
this study Fml1 was  the only conserved component of the FA path-
way in the ﬁssion yeast. Thus, following the work presented here,
the epistasis with Fan1 in ICL resolution suggests that these two
enzymes may  represent a prototypical FA pathway in S. pombe.
4.2.  The molecular function of Fan1 in ICL resolution
Very limited assumptions can be made about the function of
SpFan1 in this novel pathway of ICL repair. Data from the anal-
ysis of SpFan1 point mutants lead to the conclusion that at least
three key residues in the VRR nuc nuclease domain are required
for the function of the protein in the ICL response: D651, E666 and
K668 (Fig. 2C). In human cells, point mutations in the corresponding
residues D960, E975, K977 compromise Fan1 exo- and endonucle-
olytic activities [13,15,17]. Although biochemical studies with S.
c representing the marker selection process throughout the PEM-2 high-throughput
e to the drug cycloheximide. Step1 (blue panel): construction of the fan1::natMX6
 and selection procedures ensure the maintenance of the three markers NATR , G418R
 to nourseothricin, geneticin and cycloheximide, respectively. See supplementary
nts hus1, rad1 and rad17 with fan1. Logarithmically grown cultures were spotted in
ning the agents in the amount indicated. rad3-d is used as a standard hypersensitive
bove experiments were derived from independently constructed single deletion
. (C) Sensitivity to UV and cisplatin of the combination of pli1 and fan1 null mutants.
, the reader is referred to the web version of this article.)
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Fig. 4. Pli1 acts on a pathway of ICL repair distinct from the fan1- and the pso2-dependent systems. (A) Sensitivity of pli1-deleted mutants combined with deletions of fan1
and pso2. fan1-d: 3909 background. Logarithmically grown cultures were spotted in four 1:10 serial dilutions starting from 107 cells (ﬁrst spot on the left) on YEA plates
containing the agents in the amount indicated. rad3-d is used as a standard hypersensitive control for the efﬁcacy of the agents used. Abbreviations used: UV, ultra-violet
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trradiation; cispl, cisplatin. (B) Proposed schematic of ICL resolution in S. pombe. T
ssigned from the genetic analysis presented in this study. Left panel: possible roles
odel  of ICL resolution [48] is shown.
ombe Fan1 have not been performed, it is reasonable to speculate
hat SpFan1 acts in the ICL resolution pathway as a nuclease. The
epletion of the conserved SAP domain in Fan1 (L159P, quadru-
le mutant and N-term truncation mutant) signiﬁcantly affects its
unction. This would be consistent with a role for the conserved SAP
omain in mediating contact with the damaged substrate DNA, as
as been proposed for other proteins possessing this domain [32].
From  the limited data available thus far, it is not possible
o assign a speciﬁc function to Fan1 in processing ICL lesions.ponents of the various DNA repair pathways are shown in the relevant boxes, as
n1 in the Fan1-dependent resolution pathway. For simplicity, only the double fork
However,  it is interesting to note that the nuclease Rad13XPG has
been found to be non-epistatic with Fan1 and epistatic with Pso2
(Fig. 1B). It is tempting to speculate that another nuclease may  be
needed in the Fan1 pathway to cover the role exerted by Rad13XPG
in the Pso2 pathway. Rad13XPG (homolog of ScRad2/HsXPG) is a cru-
cial component of the nucleotide excision repair pathway, involved
in the endonucleolytic incision 3′ to the adduct [39]. Consistently
with its role in NER, it has been proposed that, in mammalian cells.
XPG would be involved in the unhooking step of the ICL pathway (3′
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f the lesion), although the ﬁnding that XPG-depleted cells are only
ildly sensitive to ICL agents suggests that other nucleases, such
s MUS81-EME1, may  also play a prominent, potentially redun-
ant, role [46,47]. It is possible that in S. pombe, as well as in higher
ukaryotes, multiple nucleases are involved in the endonucleolytic
nhooking step of ICL resolution. In the light of the biochemical
tudies with mammalian FAN1 [13–15], it can be suggested that
pFan1 may  be implicated in this reaction, either 3′ or 5′ to the
CL. It would be interesting to test the in vitro and in vivo require-
ents for various nucleases that may  be predicted to be involved at
his stage in the ﬁssion yeast, including Mus81/Eme1, the Rad16XPF,
ad13XPG and Fan1 itself.
The  biochemical data for human FAN1 indicates that this
nzyme may  be additionally involved in other stages of ICL repair.
irstly, its exonuclease activity might be required in the trimming of
he unhooked ICL. Secondly and more importantly, the signiﬁcant
efects shown for FAN1- depleted cells at late stages of homologous
epair indicate that this nuclease might be predominantly involved
n the processing of recombination intermediates generated by
reatments with DNA cross-linkers [14,15]. The data presented in
his study do not allow further conclusion on a similar role for
pFan1.
.3. The role of SUMOylation in the DNA interstrand cross-link
athway
An  interesting outcome of the cisplatin high-throughput screen
as the identiﬁcation of the increased sensitivity of the combined
an1-d pli1-d mutant compared to the parental single mutants
Table 2 and Fig. 3C). SpPli1 is a ligase involved in the post-
ranslational conjugation of small proteins named SUMO (small
biquitin-related modiﬁers). Although the exact signiﬁcance of this
onjugation (SUMOylation) is still debated, it is clear that this class
f reversible modiﬁcations plays a widespread and important role
n the regulation of eukaryotic biological processes including DNA
epair (reviewed in [38]). In the context of this study, the hypersen-
itivity of the fan1-d pli1-d mutant to cisplatin highlights a crucial
nvolvement of SUMOylation in an ICL resolution pathway distinct
rom the one in which SpFan1 is implicated. The additional epista-
is analysis presented in Fig. 4A indicates that this Pli1-dependent
CL resolution pathway is likely deﬁning an additional, third way  of
ddressing this type of adduct in S. pombe. Our study thus demon-
trates an unprecedented role for SUMOylation in the resolution
f interstrand cross-links in S. pombe which might be conserved in
igher eukaryotes.
.4.  Multiple pathways or sub-pathways of ICL resolution in
chizosaccharomyces pombe
Based on the data presented here, it is possible to delineate the
articipation of some of the components of the DNA repair machin-
ry in the resolution of interstrand cross-links in the ﬁssion yeast S.
ombe. A schematic is presented in Fig. 4B, where the known Pso2
athway of ICL resolution is paralleled by the newly identiﬁed Fan1
nd Pli1 pathways.
Fig.  4B (left panel) shows the possible molecular roles for Fan1
n the ICL resolution pathway, as discussed in the previous section.
. Conclusions
This study proﬁted from the use of the ﬁssion yeast S. pombe as
 model organism to investigate the role of novel components act-
ng in response to DNA interstrand cross-link formation, one of the
ost insidious threats posed to genomic stability. DNA interstrand
ross-linking agents are amongst the most widely used treatments
[
[ir 12 (2013) 1011– 1023
of  a wide range of cancers. Studies in mammalian systems stem-
ming from the outcome of the present work may thus ultimately
translate to an increased efﬁcacy of the current clinical options,
for instance by targeting parallel ICL repair pathways in ICL repair-
deﬁcient tumours to selectively aggravate the cytotoxicity of the
current oncological treatments.
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